Approval · Notice of Compliance 4471 · 1996
INTRON A: Notice of Compliance 4471
Issued March 19, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4471
- Date
- March 19, 1996
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Modified dosing recommendations for chronic hepatitis non-a non-B/C
- Therapeutic class
- Biological response modifier
Products in this notice
Medicinal ingredients
- INTERFERON ALFA 2B 3,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 5,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 10,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 5,000,000 UNIT per ML